Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

ALPINE2: Efficacy and safety of 14-day vs 28-day inhaled aztreonam for Pa eradication in children with cystic fibrosis.

Autor: Gilchrist FJ; Paediatric Respiratory Services, Staffordshire Children's Hospital at Royal Stoke, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK; Institute of Applied Clinical Science, Keele University, Stoke-on-Trent, UK. Electronic address: francis.gilchrist@uhnm.nhs.uk., Bui S; Bordeaux University Hospital, Hôpital Pellegrin-Enfants, Paediatric Cystic Fibrosis Reference Center (CRCM), Centre d'Investigation Clinique (CIC 1401), Bordeaux, France. Electronic address: stephanie.bui@chu-bordeaux.fr., Gartner S; Paediatric Pulmonology and Cystic Fibrosis Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Electronic address: silvia.gartner@vallhebron.cat., McColley SA; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Division of Pulmonary and Sleep Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA. Electronic address: smccolle@luriechildrens.org., Tiddens H; Department of Pediatric Pulmonology and Allergology, Erasmus MC Sophia Children's Hospital, Rotterdam, Netherlands. Electronic address: h.tiddens@erasmusmc.nl., Ruiz G; Department of Paediatric Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, UK. Electronic address: gary.ruiz@nhs.net., Stehling F; Pediatric Pulmonology and Sleep Medicine, Cystic Fibrosis Center, Children's Hospital, University Duisburg-Essen, Essen, Germany. Electronic address: florian.stehling@uk-essen.de., Alani M; Gilead Sciences Inc., Foster City, CA, USA; Division of Rheumatology, University of Washington, Seattle, WA, USA. Electronic address: muhsen.alani@gilead.com., Gurtovaya O; Gilead Sciences Inc., Foster City, CA, USA. Electronic address: Oksana.Gurtovaya@gilead.com., Bresnik M; Gilead Sciences Inc., Foster City, CA, USA. Electronic address: mbresnikmd@gmail.com., Watkins TR; Gilead Sciences Inc., Foster City, CA, USA. Electronic address: Tim.Watkins@gilead.com., Frankovic B; Gilead Sciences Inc., Foster City, CA, USA. Electronic address: Biliana.Frankovic@gilead.com., Skov M; CF Centre Copenhagen, Paediatric Pulmonary Service, Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Electronic address: marianne.skov@regionh.dk.

Publikováno v: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2024 Jan; Vol. 23 (1), pp. 80-86. Date of Electronic Publication: 2023 Jul 15.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia

Autor: Cornely, O. A., Leguay, T., Maertens, J., Vehreschild, M. J. G. T., Anagnostopoulos, A., Castagnola, C., Verga, L., Rieger, C., Kondakci, M., Harter, G., Duarte, R. F., Allione, B., Cordonnier, C., Heussel, C. P., Morrissey, C. O., Agrawal, S. G., Peter Donnelly, J., Bresnik, M., Hawkins, M. J., Garner, W., Gokbuget, N., Jarchum, G., Dictar, M., Ramirez Borga, S., Valledor, A., Knoebl, P., Greil, R., Linkesch, W., Sill, H., De Prijck, B., Sonet, A., Theunissen, K., Selleslag, D., Vargas Schwarzbold, A., Nucci, M. L. M., Lopes de Castro Lobo, C., Fogliatto, L., Bonmati, C., Turlure, P., Herbrecht, R., Thiebaut, A., Michallet, M., Egerer, G., Silling, G., Pfreundschuh, M., Hasenkamp, J., Kraemer, D. M., Topp, M., Heinz, W., Junghanss, C., Schaich, M. A., Parmentier, S., Roellig, C., Beck, H. J., Huttmann, A., Mousset, S., Duenzinger, U. N., Schwartz, S., Haerter, G., Ostermann, H., Tsirigotis, P., Matsouka, P., Angelopoulou, M. K., Karakantza, M., Spyridonidis, A., Kolomansky, A., Moses, A., Horowitz, N., Rahav, G., Aversa, F., Velardi, A., Pagano, Livio, Gentile, Giuseppe, Gobbi, M., Luppi, M., Nosari, A. M., Rambaldi, A., Candoni, A., Marbello, L., Rossi, G., Pogliani, E., Moreira, I., Nunes, A., Botelho de Sousa, A., Rubio Tejero, A. I., Vallejo, C., Vazquez, L., Besalduch Vidal, J., Gomez-Garcia de Soria, V., Jurado Chacon, M., Gonzalez Campos, J., Olavarria, E., Barba, P., de la Serna Torroba, J., Duarte, R., Heim, D., Zimmerli, S., Gerber, B., Akova, M., Bolaman, A. Z., Tabak, F., Akan, H., Senol, E.

Publikováno v: Digital.CSIC. Repositorio Institucional del CSIC
instname
Journal of Antimicrobial Chemotherapy, 72, 2359-2367
Journal of Antimicrobial Chemotherapy, 72, 8, pp. 2359-2367
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

[Objectives] To prevent invasive fungal disease (IFD) in adult patients undergoing remission-induction chemotherapy for newly diagnosed acute lymphoblastic leukaemia (ALL).
[Patients and methods] In a double-blind multicentre Phase 3 study, pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::968d8d397fdc7823486c4810640ee851
http://hdl.handle.net/10261/197645

Open label study of inhaled aztreonam for pseudomonas eradication in children with cystic fibrosis: The ALPINE study

Autor: Tiddens, H., De Boeck, Kris, Clancy, J.P., Fayon, M, Arets, H.G.M., Bresnik, M, Derchak, A, Lewis, S.A., Oermann, C.M., Malfroot, Anne

BACKGROUND: Consensus guidelines recommend early treatment to eradicate newly acquired Pseudomonas aeruginosa (Pa) infection in cystic fibrosis (CF) patients although there is no single preferred regimen. Aztreonam for inhalation solution (AZLI) sign

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3848::d9e342d7b69df20242a93d768bb11804
https://hdl.handle.net/20.500.14017/ee3002eb-5f79-4c88-b9bd-c426da070ef8